Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A302
Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
Aim of study is to collect long term safety data on enteric-coated mycophenolate sodium 720
mg bid in combination with cyclosporine with/without steroids in regard to adverse events,
serious adverse events, and patient and graft survival. After successful completion of the
study CERL080A302, patients who previously were receiving enteric-coated mycophenolate sodium
or MMF were given opportunity to remain on enteric-coated mycophenolate sodium or convert MMF
to enteric-coated mycophenolate sodium.